Analysis of the Application Effectiveness of the Pregnancy Dietary Compliance Index Scoring Tool
Download PDF
$currentUrl="http://$_SERVER[HTTP_HOST]$_SERVER[REQUEST_URI]"

Keywords

Dietary index scoring
Personalized nutrition management
Reduction
Pregnancy complications
Adverse pregnancy outcomes

DOI

10.26689/aogr.v2i3.7666

Submitted : 2024-06-24
Accepted : 2024-07-09
Published : 2024-07-24

Abstract

This study aims to conduct a dietary index score assessment for individuals with high-risk factors for gestational hyperglycemia (such as overweight, obesity, family history of diabetes, history of macrosomia, and gestational diabetes mellitus), starting from early pregnancy, and to provide personalized nutrition management based on the score to reduce pregnancy complications and adverse pregnancy outcomes. A total of 194 pregnant women who underwent routine prenatal examinations at our hospital from September 2022 to September 2023 were selected. They were randomly divided into a study group and a control group, with 97 cases in each group. The control group received simple nutritional guidance, mainly focusing on the requirements for various nutrients and nutritional supplements during each trimester. The study group received nutrition guidance based on the dietary index score, as well as personalized guidance on health education, weight management, pregnancy exercise, and lifestyle. The incidence of gestational diabetes mellitus in the intervention group was significantly lower than that in the control group, and the difference was statistically significant (P < 0.05). The incidence of macrosomia was 1.03% in the intervention group and 8.25% in the control group, with a statistically significant difference (P < 0.05). The incidence of small-for-gestational-age infants was 2.06% in the intervention group and 10.31% in the control group, with a statistically significant difference (P < 0.05). For pregnant women with high-risk factors, early pregnancy nutrition management based on the dietary compliance index score can quickly screen for nutritional risks and provide targeted personalized nutrition management, thereby reducing the risk of pregnancy complications and adverse pregnancy outcomes and promoting the health of mothers and infants during pregnancy.

References

Lepercq J, Timsit J, Mouzon SH, 2000, Etiopathogeny of Fetal Macrosomia. Journal of Gynecology Obstetrics and Human Reproduction, 29(1 Suppl): 6–12.

Xu F, Wang Z, Ding Y, et al., 2021, Establishment and Evaluation of Dietary Guideline Compliance Index in Pregnant Women. Journal of Nutrition, 43(3): 223–229.

Chinese Nutrition Society, 2022, Dietary Guidelines for Chinese Residents (2022), People’s Medical Publishing House, Beijing.

Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy: A World Health Organization Guideline, 2014, Diabetes Research and Clinical Practice, 103(3): 341–363.

Nguyen MT, Ouzounian JG, 2021, Evaluation and Management of Fetal Macrosomia. Obstetrics and Gynecology Clinics of North America, 48(2): 387–399.

Vahidi M, Asgari S, Tohidi M, et al., 2021, Macrosomia is a Risk Factor for Incident Maternal Chronic Kidney Disease. BMC Pregnancy and Childbirth, 21(1): 210.

Júnior EA, Peixoto AB, Zamarian AC, et al., 2017, Macrosomia. Best Practice & Research Clinical Obstetrics & Gynaecology, 2017(38): 83–96.

Kominiarek MA, Peaceman AM, 2017, Gestational Weight Gain. American Journal of Obstetrics and Gynecology, 217(6): 642–651.

Shulman Y, Shah BR, Berger H, et al., 2023, Prediction of Birthweight and Risk of Macrosomia in Pregnancies Complicated by Diabetes. American Journal of Obstetrics & Gynecology MFM, 5(8): 101042.

Wang YW, Chen Y, Zhang YJ, 2023, Risk Factors Combine in a Complex Manner in Assessment for Macrosomia. BMC Public Health, 23(1): 271.

Hashemipour S, Seidjavadi EH, Maleki F, et al., 2018, Level of Maternal Triglycerides is a Predictor of Fetal Macrosomia in Non-obese Pregnant Women with Gestational Diabetes Mellitus. Pediatrics and Neonatology, 59(6): 567–572.

Briana DD, Boutsikou M, Marmarinos A, et al., 2019, Perinatal Sclerostin Concentrations in Abnormal Fetal Growth: The Impact of Gestational Diabetes. The Journal of Maternal-fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 32(13): 2228–2232.

Mistry SK, Gupta RD, Alam S, et al., 2021, Gestational Diabetes Mellitus (GDM) and Adverse Pregnancy Outcome in South Asia: A Systematic Review. Endocrinology, Diabetes & Metabolism, 4(4): e00285.